Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Viazem approved in 10 European countries

Aug. 20, 1997

Preclinical results on AVI-2221 for restenosis

Aug. 19, 1997

Generic Cardizem CD open for FDA review

Aug. 19, 1997

CardioSynopsis, IHIM to co-develop novel stents

Aug. 19, 1997

New biotech company formed to combat cardiovascular diseases

Aug. 18, 1997

NIH research grant goes to Diatide for arterial thrombosis therapy

Aug. 14, 1997

Endothelin antagonists disclosed by SKB

Aug. 14, 1997

Medtronic Jewel AF enters clinical trials in U.S.

Aug. 13, 1997

Efficacy shown with roxithromycin for cardiovascular disease

Aug. 13, 1997

New angiotensin II blocker from Merck KGaA

Aug. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...